Gregory Alan Korbel - Jun 3, 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Operating Officer, Director
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
Jun 3, 2022
Transactions value $
-$6,754
Form type
4
Date filed
6/7/2022, 05:01 PM
Previous filing
Mar 14, 2022
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$6.75K -8.39K -28.11% $0.81* 21.5K Jun 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 24,334 restricted stock units